Hereditary spastic paraplegia: Clinicogenetic lessons from 608 patients

Annals of Neurology

Volumn 79, Issue 4, 2016, Pages 646-658

  Schüle, Rebecca ^a,b,c   Wiethoff, Sarah ^a,d   Martus, Peter ^b   Karle, Kathrin N ^a,b   Otto, Susanne ^e   Klebe, Stephan ^f,g,h   Klimpe, Sven ^i,j   Gallenmüller, Constanze ^k,l,m   Kurzwelly, Delia ^n,o   Henkel, Dorothea ^o,p   Rimmele, Florian ^o,q   Stolze, Henning ^g,r   Kohl, Zacharias ^s   Kassubek, Jan ^t   Klockgether, Thomas ^n,o   Vielhaber, Stefan ^o,p   Kamm, Christoph ^o,q   Klopstock, Thomas ^k,l,m   Bauer, Peter ^b   Züchner, Stephan ^c   Liepelt Scarfone, Inga ^a,b   Schöls, Ludger ^a,b,o   more..

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e ST JOSEF HOSPITAL   (Germany)

^f UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^g UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^h UNIVERSITY OF FREIBURG   (Germany)

ⁱ Department of Dermatology and Allergology   (Germany)

^j JOHANNES GUTENBERG UNIVERSITY   (Germany)

^k LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^l Germany 3 Munich Cluster for Systems Neurology   (Germany)

^m UNIVERSITY OF MUNICH   (Germany)

ⁿ UNIVERSITY HOSPITAL BONN   (Germany)

^o GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^p OTTO VON GUERICKE UNIVERSITY   (Germany)

^q UNIVERSITY OF ROSTOCK   (Germany)

^r Ev Luth Diakonissen Hospital Flensburg   (Germany)

^s UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^t UNIVERSITY OF ULM   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; ATAXIA; CHILD; CLINICAL FEATURE; COGNITIVE DEFECT; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DISEASE DURATION; DISEASE SEVERITY ASSESSMENT; DOMINANT INHERITANCE; EXTRAPYRAMIDAL SYMPTOM; FEMALE; GENETIC DIFFERENCE; GENETIC PREDISPOSITION; GENOTYPE; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE ASSESSMENT; NEWBORN; PHENOTYPE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECESSIVE INHERITANCE; RISK ASSESSMENT; SEX DIFFERENCE; SPASTIC PARAPLEGIA RATING SCALE; WALKING; GENETICS; GERMANY; MIDDLE AGED; PATHOPHYSIOLOGY; PEDIGREE; SEVERITY OF ILLNESS INDEX; SPASTIC PARAPLEGIA, HEREDITARY;

ADULT; AGED; CROSS-SECTIONAL STUDIES; FEMALE; GERMANY; HUMANS; MALE; MIDDLE AGED; PEDIGREE; SEVERITY OF ILLNESS INDEX; SPASTIC PARAPLEGIA, HEREDITARY;

EID: 84960372305     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.24611     Document Type: Article

References (58)

1. Schule R, Schols L,. Genetics of hereditary spastic paraplegias. Semin Neurol 2011; 31: 484-493.
2. Novarino G, Fenstermaker AG, Zaki MS, et al., Exome sequencing links corticospinal motor neuron disease to common neurodegenerative disorders. Science 2014; 343: 506-511.
3. Harding AE,. Classification of the hereditary ataxias and paraplegias. Lancet 1983; 1: 1151-1155.
4. Salinas S, Proukakis C, Crosby A, Warner TT,. Hereditary spastic paraplegia: clinical features and pathogenetic mechanisms. Lancet Neurol 2008; 7: 1127-1138.
5. Braschinsky M, Luus SM, Gross-Paju K, Haldre S,. The prevalence of hereditary spastic paraplegia and the occurrence of SPG4 mutations in Estonia. Neuroepidemiology 2009; 32: 89-93.
6. Erichsen AK, Koht J, Stray-Pedersen A, et al., Prevalence of hereditary ataxia and spastic paraplegia in southeast Norway: a population-based study. Brain 2009; 132 (pt 6): 1577-1588.
7. Ruano L, Melo C, Silva MC, Coutinho P,. The global epidemiology of hereditary ataxia and spastic paraplegia: a systematic review of prevalence studies. Neuroepidemiology 2014; 42: 174-183.
8. Pensato V, Castellotti B, Gellera C, et al., Overlapping phenotypes in complex spastic paraplegias SPG11, SPG15, SPG35 and SPG48. Brain 2014; 137 (pt 7): 1907-1920.
9. Coutinho P, Ruano L, Loureiro JL, et al., Hereditary ataxia and spastic paraplegia in Portugal: a population-based prevalence study. JAMA Neurol 2013; 70: 746-755.
10. Klebe S, Depienne C, Gerber S, et al., Spastic paraplegia gene 7 in patients with spasticity and/or optic neuropathy. Brain 2012; 135 (pt 10): 2980-2993.
11. van Gassen KL, van der Heijden CD, de Bot ST, et al., Genotype-phenotype correlations in spastic paraplegia type 7: a study in a large Dutch cohort. Brain 2012; 135 (pt 10): 2994-3004.
12. Goizet C, Boukhris A, Maltete D, et al., SPG15 is the second most common cause of hereditary spastic paraplegia with thin corpus callosum. Neurology 2009; 73: 1111-1119.
13. Beetz C, Schule R, Deconinck T, et al., REEP1 mutation spectrum and genotype/phenotype correlation in hereditary spastic paraplegia type 31. Brain 2008; 131 (pt 4): 1078-1086.
14. Goizet C, Boukhris A, Durr A, et al., CYP7B1 mutations in pure and complex forms of hereditary spastic paraplegia type 5. Brain 2009; 132 (pt 6): 1589-1600.
15. Stevanin G, Azzedine H, Denora P, et al., Mutations in SPG11 are frequent in autosomal recessive spastic paraplegia with thin corpus callosum, cognitive decline and lower motor neuron degeneration. Brain 2008; 131 (pt 3): 772-784.
16. Hehr U, Bauer P, Winner B, et al., Long-term course and mutational spectrum of spatacsin-linked spastic paraplegia. Ann Neurol 2007; 62: 656-665.
17. Namekawa M, Ribai P, Nelson I, et al., SPG3A is the most frequent cause of hereditary spastic paraplegia with onset before age 10 years. Neurology 2006; 66: 112-114.
18. Durr A, Davoine CS, Paternotte C, et al., Phenotype of autosomal dominant spastic paraplegia linked to chromosome 2. Brain 1996; 119 (pt 5): 1487-1496.
19. Schule R, Holland-Letz T, Klimpe S, et al., The Spastic Paraplegia Rating Scale (SPRS): a reliable and valid measure of disease severity. Neurology 2006; 67: 430-434.
20. Beetz C, Nygren AO, Schickel J, et al., High frequency of partial SPAST deletions in autosomal dominant hereditary spastic paraplegia. Neurology 2006; 67: 1926-1930.
21. Beetz C, Schule R, Klebe S, et al., Screening of hereditary spastic paraplegia patients for alterations at NIPA1 mutational hotspots. J Neurol Sci 2008; 268: 131-135.
22. Schule R, Kremer BP, Kassubek J, et al., SPG10 is a rare cause of spastic paraplegia in European families. J Neurol Neurosurg Psychiatry 2008; 79: 584-587.
23. Schule R, Brandt E, Karle KN, et al., Analysis of CYP7B1 in non-consanguineous cases of hereditary spastic paraplegia. Neurogenetics 2009; 10: 97-104.
24. Schule R, Schlipf N, Synofzik M, et al., Frequency and phenotype of SPG11 and SPG15 in complicated hereditary spastic paraplegia. J Neurol Neurosurg Psychiatry 2009; 80: 1402-1404.
25. Schlipf NA, Beetz C, Schule R, et al., A total of 220 patients with autosomal dominant spastic paraplegia do not display mutations in the SLC33A1 gene (SPG42). Eur J Hum Genet 2010; 18: 1065-1067.
26. Schlipf NA, Schule R, Klimpe S, et al., Amplicon-based high-throughput pooled sequencing identifies mutations in CYP7B1 and SPG7 in sporadic spastic paraplegia patients. Clin Genet 2011; 80: 148-160.
27. Dufke C, Schlipf N, Schule R, et al., A high-throughput resequencing microarray for autosomal dominant spastic paraplegia genes. Neurogenetics 2012; 13: 215-227.
28. Gonzalez M, Nampoothiri S, Kornblum C, et al., Mutations in phospholipase DDHD2 cause autosomal recessive hereditary spastic paraplegia (SPG54). Eur J Hum Genet 2013; 21: 1214-1218.
29. Oates EC, Rossor AM, Hafezparast M, et al., Mutations in BICD2 cause dominant congenital spinal muscular atrophy and hereditary spastic paraplegia. Am J Hum Genet 2013; 92: 965-973.
30. Caballero Oteyza A, Battaloglu E, Ocek L, et al., Motor protein mutations cause a new form of hereditary spastic paraplegia. Neurology 2014; 82: 2007-2016.
31. Synofzik M, Gonzalez MA, Lourenco CM, et al., PNPLA6 mutations cause Boucher-Neuhauser and Gordon Holmes syndromes as part of a broad neurodegenerative spectrum. Brain 2014; 137 (pt 1): 69-77.
32. Gonzalez MA, Lebrigio RF, Van Booven D, et al., GEnomes Management Application (GEM.app): a new software tool for large-scale collaborative genome analysis. Hum Mutat 2013; 34: 842-846.
33. Durr A, Camuzat A, Colin E, et al., Atlastin1 mutations are frequent in young-onset autosomal dominant spastic paraplegia. Arch Neurol 2004; 61: 1867-1872.
34. Gray KA, Yates B, Seal RL, et al., Genenames.org: the HGNC resources in 2015. Nucleic Acids Res 2015; 43 (Database issue): D1079-D1085.
35. Rossor AM, Oates EC, Salter HK, et al., Phenotypic and molecular insights into spinal muscular atrophy due to mutations in BICD2. Brain 2015; 138 (pt 2): 293-310.
36. Depienne C, Tallaksen C, Lephay JY, et al., Spastin mutations are frequent in sporadic spastic paraparesis and their spectrum is different from that observed in familial cases. J Med Genet 2006; 43: 259-265.
37. Brugman F, Scheffer H, Wokke JH, et al., Paraplegin mutations in sporadic adult-onset upper motor neuron syndromes. Neurology 2008; 71: 1500-1505.
38. Margolin DH, Kousi M, Chan YM, et al., Ataxia, dementia, and hypogonadotropism caused by disordered ubiquitination. N Engl J Med 2013; 368: 1992-2003.
39. Bonifert T, Karle KN, Tonagel F, et al., Pure and syndromic optic atrophy explained by deep intronic OPA1 mutations and an intralocus modifier. Brain 2014; 137 (pt 8): 2164-2177.
40. Mencarelli MA, Heidet L, Storey H, et al., Evidence of digenic inheritance in Alport syndrome. J Med Genet 2015; 52: 163-174.
41. Lupski JR,. Digenic inheritance and Mendelian disease. Nat Genet 2012; 44: 1291-1292.
42. Anheim M, Tranchant C, Koenig M,. The autosomal recessive cerebellar ataxias. N Engl J Med 2012; 366: 636-646.
43. Proukakis C, Moore D, Labrum R, et al., Detection of novel mutations and review of published data suggests that hereditary spastic paraplegia caused by spastin (SPAST) mutations is found more often in males. J Neurol Sci 2011; 306: 62-65.
44. Varga RE, Schule R, Fadel H, et al., Do not trust the pedigree: reduced and sex-dependent penetrance at a novel mutation hotspot in ATL1 blurs autosomal dominant inheritance of spastic paraplegia. Hum Mutat 2013; 34: 860-863.
45. Fonknechten N, Mavel D, Byrne P, et al., Spectrum of SPG4 mutations in autosomal dominant spastic paraplegia. Hum Mol Genet 2000; 9: 637-644.
46. Sauter S, Miterski B, Klimpe S, et al., Mutation analysis of the spastin gene (SPG4) in patients in Germany with autosomal dominant hereditary spastic paraplegia. Hum Mutat 2002; 20: 127-132.
47. Depienne C, Fedirko E, Forlani S, et al., Exon deletions of SPG4 are a frequent cause of hereditary spastic paraplegia. J Med Genet 2007; 44: 281-284.
48. Hazan J, Fonknechten N, Mavel D, et al., Spastin, a new AAA protein, is altered in the most frequent form of autosomal dominant spastic paraplegia. Nat Genet 1999; 23: 296-303.
49. Vermeer S, Meijer RP, Pijl BJ, et al., ARSACS in the Dutch population: a frequent cause of early-onset cerebellar ataxia. Neurogenetics 2008; 9: 207-214.
50. Ragno M, De Michele G, Cavalcanti F, et al., Broadened Friedreich's ataxia phenotype after gene cloning. Minimal GAA expansion causes late-onset spastic ataxia. Neurology 1997; 49: 1617-1620.
51. Bhidayasiri R, Perlman SL, Pulst SM, Geschwind DH,. Late-onset Friedreich ataxia: phenotypic analysis, magnetic resonance imaging findings, and review of the literature. Arch Neurol 2005; 62: 1865-1869.
52. Schols L, Bauer P, Schmidt T, et al., Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis. Lancet Neurol 2004; 3: 291-304.
53. Muller vom Hagen J, Karle KN, Schule R, et al., Leukodystrophies underlying cryptic spastic paraparesis: frequency and phenotype in 76 patients. Eur J Neurol 2014; 21: 983-988.
54. Tezenas du Montcel S, Charles P, Goizet C, et al., Factors influencing disease progression in autosomal dominant cerebellar ataxia and spastic paraplegia. Arch Neurol 2012; 69: 500-508.
55. Jacobi H, Bauer P, Giunti P, et al., The natural history of spinocerebellar ataxia type 1, 2, 3, and 6: a 2-year follow-up study. Neurology 2011; 77: 1035-1041.
56. Metz G, Coppard N, Cooper JM, et al., Rating disease progression of Friedreich's ataxia by the International Cooperative Ataxia Rating Scale: analysis of a 603-patient database. Brain 2013; 136 (pt 1): 259-268.
57. Reetz K, Dogan I, Costa AS, et al., Biological and clinical characteristics of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS) cohort: a cross-sectional analysis of baseline data. Lancet Neurol 2015; 14: 174-182.
58. Tabrizi SJ, Scahill RI, Owen G, et al., Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data. Lancet Neurol 2013; 12: 637-649.